Effect of octreotide on mouth-to-caecum transit time in healthy subjects and in the irritable bowel syndrome.
The effect of a single subcutaneous injection of octreotide (50 micrograms) on mouth-to-caecum transit time was determined in patients with the irritable bowel syndrome who complained of bowel frequency, and in healthy volunteers. The assessment of mouth-to-caecum transit time was performed by monitoring breath hydrogen concentration and noting a sustained 10 p.p.m. rise after ingestion of lactulose 40 ml. Measurements were performed fasting, and on a separate day, after a standard breakfast which included 40 ml lactulose. The studies were performed double-blind in a pre-determined random order. Octreotide prolonged mouth-to-caecum transit time in irritable bowel syndrome patients and healthy subjects by factors of 2.4 and 2.6 after lactulose when fasting, respectively, and by factors of 2.8 and 2.6 after the breakfast which contained lactulose. The upper gastrointestinal transit rate was similar in irritable bowel syndrome patients and healthy controls.
O'Donnell
L J
LJ
Department of Gastroenterology, St Bartholomew's Hospital, London, UK.
Watson
A J
AJ
Cameron
D
D
Farthing
M J
MJ
D000328:Adult; D002432:Cecum / Q000378:metabolism; D003109:Colonic Diseases, Functional / Q000503:physiopathology*; D004311:Double-Blind Method; D005260:Female; D005772:Gastrointestinal Transit / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000494:pharmacology*; D011897:Random Allocation
D015282:Octreotide